Compounds

US8937176B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Klaus Rudolf · Warthausen, DE
• Daniel Bischoff · Grand Rapids, US
• Georg Dahmann · Biberach an der Riß, DE
• Matthias Grauert · Ingelheim am Rhein, DE
• Raimund Kuelzer · Mittelbiberach, DE

Key dates

• Filing date: Dec 10, 2012
• Grant date: Jan 20, 2015
• Expiry date: Jun 28, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D403/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

This invention relates to compounds of formula Itheir use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.